Raquel Robelin v. Spectrum Health Hospitals

CourtMichigan Supreme Court
DecidedDecember 22, 2010
Docket139860
StatusPublished

This text of Raquel Robelin v. Spectrum Health Hospitals (Raquel Robelin v. Spectrum Health Hospitals) is published on Counsel Stack Legal Research, covering Michigan Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Raquel Robelin v. Spectrum Health Hospitals, (Mich. 2010).

Opinion

Order Michigan Supreme Court Lansing, Michigan

December 22, 2010 Marilyn Kelly, Chief Justice

Michael F. Cavanagh Maura D. Corrigan 139860 Robert P. Young, Jr. Stephen J. Markman Diane M. Hathaway RAQUEL ROBELIN, Conservator, for Alton Thomas Davis, Justices TEIJA McCALL, Plaintiff-Appellee, v SC: 139860 COA: 279780 Kent CC: 04-010444-NH SPECTRUM HEALTH HOSPITALS, d/b/a SPECTRUM HEALTH-EAST CAMPUS, JOHN HARTMANN, M.D., and ADVANTAGE HEALTH PHYSICIANS, P.C., Defendants-Appellants. _________________________________________/

On November 4, 2010, the Court heard oral argument on the application for leave to appeal the September 10, 2009 judgment of the Court of Appeals. On order of the Court, the application is again considered, and it is DENIED, there being no majority in favor of granting leave to appeal or taking other action.

KELLY, C.J. (concurring).

I concur with the order denying leave to appeal I do not believe that the lower courts misapplied the legal standards governing the admissibility of expert testimony or that allowing the testimony of plaintiff’s expert was improper.

FACTS AND PROCEEDINGS

Plaintiff’s daughter, McCall, was born at defendant Spectrum Hospital in 2001. Shortly after her birth, she suffered a neonatal stroke. As a result, she is unable to walk without assistance and has had significant developmental delays in language and speech.

Plaintiff filed this medical malpractice action in 2004, alleging that McCall suffered hypoxia, which caused the stroke, which in turn caused neurological disabilities. The parties dispute when the stroke occurred and whether the health care professionals missed indicators of it. 2

In 2008, defendants moved to strike the testimony of Dr. Ronald Gabriel, plaintiff’s causation expert. The trial court held a Daubert1 hearing on the issue but ultimately denied the motion. The Court of Appeals denied interlocutory leave to appeal and denied defendants’ motion for a peremptory reversal. Defendants appealed here, and we remanded the case to the Court of Appeals for consideration as on leave granted.2

In 2009, on remand, the Court of Appeals affirmed the trial court’s ruling denying defendants’ motion to exclude Dr. Gabriel’s testimony.3 The panel ruled that the trial court had been correct in concluding that Dr. Gabriel simply used the process of elimination, a time-honored and well-tested means of reaching a conclusion.

In 2010, defendants again sought leave to appeal in this Court. We heard oral argument on the application.4

ANALYSIS

MCL 600.2955(1) and MRE 702 require that an expert’s opinion be “reliable,” “assist the trier of fact,” and be “the product of reliable principles and methods.”5 The Court of Appeals has held that, as long as the basic methodology and principles utilized by an expert are “sound and create a trustworthy foundation for the conclusion reached, the expert testimony is admissible no matter how novel.”6

In this case, the trial court did not use the magic word “reliable” or the phrase “will assist the trier of fact.” However, the trial court conducted a lengthy two-day Daubert hearing to evaluate Dr. Gabriel’s proposed testimony. The court concluded that the testimony has “a foundation in fact and in science, and is based, at least in reasonable degree, upon demonstrable data.”

In that ruling, the court discussed its “gatekeeping function” under Daubert and addressed each of the factors in MCL 600.2955(1). It certainly does not appear to me, as

1 Daubert v Merrell Dow Pharmaceuticals Inc, 509 US 579; 113 S Ct 2786 (1993). 2 Robelin v Spectrum Health Hospitals, 482 Mich 985 (2008). 3 Robelin v Spectrum Health Hospitals, unpublished opinion per curiam of the Court of Appeals, issued September 10, 2009 (Docket No. 279780). 4 Robelin v Spectrum Health Hospitals, 486 Mich 851 (2010). 5 MCL 600.2955(1); MRE 702. 6 Nelson v American Sterilizer Co (On Remand), 223 Mich App 485, 492 (1997), citing Daubert, 509 US at 596. 3

it does to the dissenters, that the trial court’s ruling involved an “oversight” as to what was required of it.

The dissenters also criticize the trial court’s application to Dr. Gabriel’s testimony of the factors set forth in MCL 600.2955(1)(a), (b), (e), and (g). Contrary to the dissenters, I believe that the trial court did conclude that Dr. Gabriel’s theory had been subject to testing under MCL 600.2955(1)(a). The court noted that it would be impracticable to do prospective studies of this sort, so “replication” was impossible. However, it pointed to retrospective studies analyzing data that “does seem to indicate some causal nexus between hypoxia in the prenatal state and a neonatal stroke.”

Regarding factor (b), the court explicitly found that journal articles in the record seemingly demonstrated the causal nexus that Dr. Gabriel asserted and had been subject to peer review. Hence, his opinion on causation and its basis have been subject to peer review. It appears that the dissent reads MCL 600.2955(1)(b) as requiring that a peer- reviewed article mention Dr. Gabriel by name and attribute the opinion specifically to him. This is an overly restrictive view of factor (b). The only requirement in MCL 600.2955(1)(b) is that the expert opinion and its basis have been subjected to peer review.

Regarding factor (g), the trial court specifically found that “the articles referenced certainly are outside the context of litigation.” Simply because Dr. Gabriel’s opinion is retrospective in nature does not preclude it or his methodology from being used outside the context of litigation.

Regarding factor (e), I agree with the dissent that the trial court should have considered a “relevant expert community” expanding beyond plaintiff’s and defendants’ experts. This factor directs trial courts to consider whether an opinion and its basis are generally accepted by “individuals who are knowledgeable in the field of study and are gainfully employed applying that knowledge on the free market.” Thus, the trial court should have considered the broader expert community when evaluating this factor.

Nonetheless, because the trial court otherwise fulfilled its gatekeeper function, I do not believe that its misapplication of one of many evaluative criteria warrants reversal. Moreover, the trial court also applied the three other factors from MCL 600.2955(1), and the dissent does not take issue with its application of those factors.

The dissenters similarly err in their criticisms of the Court of Appeals decision. Their criticisms are premised on its conclusion that Dr. Gabriel’s retrospective use of the process of elimination is flawed because there are no known predictors of neonatal strokes. Therefore, supposedly, defendants could not have acted prospectively to prevent McCall’s stroke. However, Dr. Gabriel’s proposed testimony was that evidence arising before and after McCall’s birth demonstrated that she experienced hypoxia and a decreased heart output, leading to a blood clot and stroke. The medical literature in the 4

record establishes that perinatal asphyxia is considered the most common cause of neonatal stroke. If the treating physicians could have discerned that McCall suffered hypoxia, it was foreseeable that she could suffer a neonatal stroke. Thus, Chapin v A & L Parts Inc,7 is not distinguishable and Dr. Gabriel’s testimony was properly admitted.

Moreover, the dissenters assert that Dr. Gabriel’s process of elimination methodology fails to establish that whatever remains is a proximate cause of the alleged injury. They are mistaken. It is certainly true that “correlation does not equal causation.”8 However, this argument has nothing to do with the reliability of Dr. Gabriel’s opinion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Robelin v. Spectrum Health Hospitals
780 N.W.2d 298 (Michigan Supreme Court, 2010)
Robelin v. SPECTRUM HEALTH HOSPITALS
755 N.W.2d 631 (Michigan Supreme Court, 2008)
Johanna Woodard v. University of Mich Medical Ctr
476 Mich. 545 (Michigan Supreme Court, 2006)
Gilbert v. DaimlerChrysler Corp.
685 N.W.2d 391 (Michigan Supreme Court, 2004)
Nelson v. American Sterilizer Co.
566 N.W.2d 671 (Michigan Court of Appeals, 1997)
Craig v. Oakwood Hospital
684 N.W.2d 296 (Michigan Supreme Court, 2004)
Chapin v. a & L PARTS, INC.
732 N.W.2d 578 (Michigan Court of Appeals, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Raquel Robelin v. Spectrum Health Hospitals, Counsel Stack Legal Research, https://law.counselstack.com/opinion/raquel-robelin-v-spectrum-health-hospitals-mich-2010.